Overview
- Species: Human
- Keywords: iPSC-derived cells
- iPSC: iPSC-Derived Cardiomyocytes
- Features: cryopreserved, male
- Cell Type: Muscle Cells
- Features:kit
iPSC-derived Human Cardiomyocytes with Media
Cat.-Nr.: ASE-9703
Description
Applied StemCell has developed an efficient integration-free, small molecule-based method to differentiate high-quality cardiomyocytes from human iPSCs. The differentiated cardiomyocytes recapitulate the phenotype and functional parameters of primary and in vivo cardiomyocytes.
We provide cardiomyocytes differentiated from an integration-free, control human iPSC line (ASE-9211), reprogrammed from fibroblasts of an African American male donor. These high-purity (>80%) cells express high levels of cTnT. The cryopreserved cardiomyocytes are ready to use in 2-3 days after recovery, and are functionally viable for 7-14 days after recovery.
These iPSC-differentiated cardiomyocytes can be used as control lines to compare phenotype and functionality of patient-derived, genome-edited iPSC-derived cardiomyocytes for drug screening applications.
SUPPLIER:
Applied StemCell
STATUS:
In Stock
SIZE:
1 pcs
iPSC-derived Human Cardiomyocytes with Media (iPSCs from Fibroblasts, iPSC Line ASE-9211, African American Male, Neonatal, Episomal)
